&lt;Strong Point Inc> said itsPharmaceutical Technologies Inc subsidiary will market inEurope its Immunol-RD nutritional product, designed to protectindividuals exposed to medium or minimal radiation dosagelevels.    The company said it will market the product in Europebecause of the radiation exposure from the Chernobyl nucelarpower accident.    The company asserted that the product can offset thedeleterious effects of radiation, which weakens the immunesystem. Reuter&#3;